Deep White Matter Lesions Are Associated with Early Recognition of Dementia in Alzheimer’s Disease

Hiroo Kasahara; Masaki Ikeda; Kazuaki Nagashima; YUKIO FUJITA; Kouki Makioka; Setsuki Tsukagoshi; Tsuneo Yamazaki; Eriko Takai; Etsuko Sanada; Ayumi Kobayashi; Kazuhiro Kishi; Takayuki Suto; Tetsuya Higuchi; Yoshito Tsushima; Yoshio Ikeda

doi:10.3233/jad-180939

journal article Mar 29, 2019

Deep White Matter Lesions Are Associated with Early Recognition of Dementia in Alzheimer’s Disease

Hiroo Kasahara Masaki Ikeda Kazuaki Nagashima YUKIO FUJITA Kouki Makioka Setsuki Tsukagoshi Tsuneo Yamazaki Eriko Takai Etsuko Sanada Ayumi Kobayashi Kazuhiro Kishi Takayuki Suto Tetsuya Higuchi Yoshito Tsushima Yoshio Ikeda

Journal of Alzheimer’s Disease Vol. 68 No. 2 pp. 797-808 · SAGE Publications

View at Publisher Save 10.3233/jad-180939

Topics

No keywords indexed for this article. Browse by subject →

References

61

[1]

Neuropathological stageing of Alzheimer-related changes

H. Braak, E. Braak

Acta Neuropathologica 1991 10.1007/bf00308809

[2]

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

Dietmar R. Thal, Udo Rüb, Mario Orantes et al.

Neurology 2002 10.1212/wnl.58.12.1791

[3]

Klunk "Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B" Ann Neurol (2004) 10.1002/ana.20009

[4]

Rowe "Imaging beta-amyloid burden in aging and dementia" Neurology (2007) 10.1212/01.wnl.0000261919.22630.ea

[5]

Aizenstein "Frequent amyloid deposition without significant cognitive impairment among the elderly" Arch Neurol (2008) 10.1001/archneur.65.11.1509

[6]

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

Clifford R. Jack, Val J. Lowe, Matthew L. Senjem et al.

Brain 2008 10.1093/brain/awm336

[7]

Kivipelto "Midlife vascular risk factors and Alzheimer’s disease in later life: Longitudinal, population based study" BMJ (2001) 10.1136/bmj.322.7300.1447

[8]

Li "Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease" Neurology (2011) 10.1212/wnl.0b013e318217e7a4

[9]

Cheng "Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies" Intern Med J (2012) 10.1111/j.1445-5994.2012.02758.x

[10]

Kemppainen "Brain amyloid load and its associations with cognition and vascular risk factors in FINGER study" Neurology (2017) 10.1212/wnl.0000000000004827

[11]

Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older persons

Hazel Mae A Abraham, Leslie Wolfson, Nicola Moscufo et al.

Journal of Cerebral Blood Flow & Metabolism 2016 10.1038/jcbfm.2015.121

[12]

Pantoni "The relation between white-matter lesions and cognition" Curr Opin Neurol (2007) 10.1097/wco.0b013e328172d661

[13]

Potter "Cerebral perivascular spaces visible on magnetic resonance imaging: Development of a qualitative rating scale and its observer reliability" Cerebrovasc Dis (2015) 10.1159/000375153

[14]

Provenzano "White matter hyperintensities and cerebral amyloidosis: Necessary and sufficient for clinical expression of Alzheimer disease?" JAMA Neurol (2013) 10.1001/jamaneurol.2013.1321

[15]

Zhou "White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer’s disease patients" J Magn Reson Imaging (2015) 10.1002/jmri.24550

[16]

Roseborough "Associations between amyloid beta and white matter hyperintensities: A systematic review" Alzheimers Dement (2017) 10.1016/j.jalz.2017.01.026

[17]

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Guy M. McKhann, David S. Knopman, Howard Chertkow et al.

Alzheimer's & Dementia 2011 10.1016/j.jalz.2011.03.005

[18]

“Mini-mental state”

Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh

Journal of Psychiatric Research 1975 10.1016/0022-3956(75)90026-6

[19]

The FAB

B. Dubois, A. Slachevsky, I. Litvan et al.

Neurology 2000 10.1212/wnl.55.11.1621

[20]

The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

Ziad S. Nasreddine, Natalie A. Phillips, Valérie Bédirian et al.

Journal of the American Geriatrics Society 2005 10.1111/j.1532-5415.2005.53221.x

[21]

Fujiwara "Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the Montreal Cognitive Assessment" Geriatr Gerontol Int (2010) 10.1111/j.1447-0594.2010.00585.x

[22]

Sheikh "Proposed factor structure of the Geriatric Depression Scale" Int Psychogeriatr (1991) 10.1017/s1041610291000480

[23]

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

M. P. Lawton, E. M. Brody

The Gerontologist 1969 10.1093/geront/9.3_part_1.179

[24]

Fazekas "MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging" AJR Am J Roentgenol (1987) 10.2214/ajr.149.2.351

[25]

MacLullich "Enlarged perivascular spaces are associated with cognitive function in healthy elderly men" J Neurol Neurosurg Psychiatry (2004) 10.1136/jnnp.2003.030858

[26]

Mathis "Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents" J Med Chem (2003) 10.1021/jm030026b

[27]

Ikeda "CSF levels of Abeta1-38/Abeta1-40/Abeta1-42 and (11)C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer’s disease" Amyloid (2014) 10.3109/13506129.2014.949231

[28]

Lopresti "Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: A comparative analysis" J Nucl Med (2005)

[29]

McNamee "Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements" J Nucl Med (2009) 10.2967/jnumed.108.057612

[30]

Yamane "Inter-rater variability of visual interpretation and comparison with quantitative evaluation of (11)C-PiB PET amyloid images of the Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI) multicenter study" Eur J Nucl Med Mol Imaging (2017) 10.1007/s00259-016-3591-2

[31]

Wenham "Apolipoprotein E genotyping by one-stage PCR" Lancet (1991) 10.1016/0140-6736(91)92823-k

[32]

National Institute on Aging/Alzheimer’s Association Working Group "Apolipoprotein E genotyping in Alzheimer’s disease" Lancet (1996) 10.1016/s0140-6736(96)90284-6

[33]

Godin "Apolipoprotein E genotype is related to progression of white matter lesion load" Stroke (2009) 10.1161/strokeaha.109.555839

[34]

Mahley "Apolipoprotein E: Far more than a lipid transport protein" Annu Rev Genomics Hum Genet (2000) 10.1146/annurev.genom.1.1.507

[35]

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

E. H. Corder, A. M. Saunders, W. J. Strittmatter et al.

Science 1993 10.1126/science.8346443

[36]

Saunders "Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease" Neurology (1993) 10.1212/wnl.43.8.1467

[37]

Saunders "Apolipoprotein E and Alzheimer disease: An update on genetic and functional analyses" J Neuropathol Exp Neurol (2000) 10.1093/jnen/59.9.751

[38]

Rezek "Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal aging" Neurology (1987) 10.1212/wnl.37.8.1365

[39]

Scheltens "White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer’s disease. Evidence for heterogeneity" Brain (1992) 10.1093/brain/115.3.735

[40]

Meyer "White matter lesions in the elderly" J Neurol Sci (1992) 10.1016/0022-510x(92)90002-3

[41]

Kalaria "The role of cerebral ischemia in Alzheimer’s disease" Neurobiol Aging (2000) 10.1016/s0197-4580(00)00125-1

[42]

Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease

Kirsty E. McAleese, Lauren Walker, Sophie Graham et al.

Acta Neuropathologica 2017 10.1007/s00401-017-1738-2

[43]

Rouhl "Virchow-Robin spaces relate to cerebral small vessel disease severity" J Neurol (2008) 10.1007/s00415-008-0777-y

[44]

Yao "Dilated perivascular spaces in small-vessel disease: A study in CADASIL" Cerebrovasc Dis (2014) 10.1159/000356982

[45]

Zhu "Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: A population-based study" Stroke (2010) 10.1161/strokeaha.110.591586

[46]

Hiroki "Linear hyperintensity objects on magnetic resonance imaging related to hypertension" Cerebrovasc Dis (2001) 10.1159/000047633

[47]

Patankar "Dilatation of the Virchow-Robin space is a sensitive indicator of cerebral microvascular disease: Study in elderly patients with dementia" AJNR Am J Neuroradiol (2005)

[48]

Vermeer "Silent brain infarcts and the risk of dementia and cognitive decline" N Engl J Med (2003) 10.1056/nejmoa022066

[49]

Engler "Two-year follow-up of amyloid deposition in patients with Alzheimer’s disease" Brain (2006) 10.1093/brain/awl178

[50]

Mintun "[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease" Neurology (2006) 10.1212/01.wnl.0000228230.26044.a4

Showing 50 of 61 references

Metrics

9

Citations

61

References

Details

Published: Mar 29, 2019
Vol/Issue: 68(2)
Pages: 797-808

Authors

H

Hiroo Kasahara

Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan

M

Masaki Ikeda

Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan

K

Kazuaki Nagashima

Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan

Y

YUKIO FUJITA

Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan

K

Kouki Makioka

Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan

S

Setsuki Tsukagoshi

Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan

T

Tsuneo Yamazaki

Department of Rehabilitation, Gunma University Graduate School of Health Sciences, Maebashi, Japan

E

Eriko Takai

Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan

E

Etsuko Sanada

Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan

A

Ayumi Kobayashi

Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan

K

Kazuhiro Kishi

Department of Radiology, Gunma University Hospital, Maebashi, Japan

T

Takayuki Suto

Department of Radiology, Gunma University Hospital, Maebashi, Japan

T

Tetsuya Higuchi

Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan

Y

Yoshito Tsushima

Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan

Y

Yoshio Ikeda

Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan

Cite This Article

Hiroo Kasahara, Masaki Ikeda, Kazuaki Nagashima, et al. (2019). Deep White Matter Lesions Are Associated with Early Recognition of Dementia in Alzheimer’s Disease. Journal of Alzheimer’s Disease, 68(2), 797-808. https://doi.org/10.3233/jad-180939

Deep White Matter Lesions Are Associated with Early Recognition of Dementia in Alzheimer’s Disease

You May Also Like